Manuscripts

Search by keyword, year, or author name.

Showing 1543 manuscripts.

Induction of cytokines in normal placental cells by the human immunodeficiency virus

James M. Reuben, B. Gonik, Siyu Li, Jim A. Turpin. Induction of cytokines in normal placental cells by the human immunodeficiency virus. Lymphokine and Cytokine Research. 1991. 10: 195-9.

Year

1991

Journal

Lymphokine and Cytokine Research

A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease

Ross E. McKinney. A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease. New England Journal of Medicine. 1991. 324: 1018-1025.

Year

1991

Journal

New England Journal of Medicine

Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection

T. Tartaglione, T. Tartaglione, Ann C. Collier, Kent Opheim, F. G. Gianola, Jacqueline K. Benedetti, Lawrence Corey. Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. 1991. 35: 2225-31.

Year

1991

Journal

Antimicrobial Agents and Chemotherapy

Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men

Walter T. Hughes, Wren Kennedy, Jerry L. Shenep, Patricia M. Flynn, Seth Hetherington, Glenda H. Fullen, Danny Lancaster, Daniel S. Stein, Steven Palte, Deborah Rosenbaum, San H.T. Liao, M. Robert Blum, Michael D. Rogers. Safety and pharmacokinetics of 566C80, a hydroxynaphthoquinone with anti-Pneumocystis carinii activity: a phase I study in human immunodeficiency virus (HIV)-infected men. Journal of Infectious Diseases. 1991. 163: 843-8.

Year

1991

Journal

Journal of Infectious Diseases

A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma

Margaret A. Fischl, Raj B. Uttamchandani, Lionel Resnick, Ram Agarwal, Mary Ann Fletcher, Janie Reese, Lisa Dearmas, Jane Chidekel, Mary McCann, Mark Myers. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 1-10.

Year

1991

Journal

Journal of Acquired Immune Deficiency Syndromes

Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS

Susan E. Krown, Donna Niedzwiecki, R. B. Bhalla, Neal Flomenberg, Denise Bundow, D. Chapman. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 871-80.

Year

1991

Journal

Journal of Acquired Immune Deficiency Syndromes

Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus

David H. Schwartz, Gail Skowron, Thomas C. Merigan. Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virus. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 11-23.

Year

1991

Journal

Journal of Acquired Immune Deficiency Syndromes

Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients

Charles Rinaldo, Charles Rinaldo, Xiao-Li Huang, P. Piazza, John A. Armstrong, G. Rappocciolo, George J. Pazin, Deborah McMahon, Phalguni Gupta, Z. Fan, Zhi-Qiang Zhang. Augmentation of cellular immune function during the early phase of zidovudine treatment of AIDS patients. Journal of Infectious Diseases. 1991. 164: 638-45.

Year

1991

Journal

Journal of Infectious Diseases

Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection

Charles Flexner, Patricia Barditch-Crovo, David Kornhauser, Homayoon Farzadegan, Lynda Nerhood, Richard E. Chaisson, Kathleen M. Bell, Kevin Lorentsen, Craig Hendrix, Brent Gray Petty, Paul S. Lietman. Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection. Antimicrobial Agents and Chemotherapy. 1991. 35: 2544-50.

Year

1991

Journal

Antimicrobial Agents and Chemotherapy

Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis

Kenneth A. Freedberg, AN Tosteson, Calvin J. Cohen, Deborah Jean Cotton. Primary prophylaxis for Pneumocystis carinii pneumonia in HIV-infected people with CD4 counts below 200/mm3: a cost-effectiveness analysis. Journal of Acquired Immune Deficiency Syndromes. 1991. 4: 521-31.

Year

1991

Journal

Journal of Acquired Immune Deficiency Syndromes